The presence of type 2 diabetes is considered a risk factor for the development of chronic kidney disease (CKD). Simple screening measures based on blood and urine samples can detect CKD at an early stage. This is becoming increasingly important, as the progression of kidney failure – especially in the early stages – can now be effectively delayed with medication.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
- CARDIOVASC
- Nephrologie-Special
Related Topics
You May Also Like
- Evidence, pathophysiology and management in the light of current data
Heart failure with improved ejection fraction (HFimpEF)
- Early rheumatoid arthritis
C1M has potential as a biomarker
- Osteoporosis
Risk-stratified therapy with osteoanabolic agents improves outcomes
- "Swiss Health Care Atlas"
New indicator: medication for weight regulation
- AI in neurology
Control instead of a flood of data: AI makes big data and wearables usable
- Longevity Medicine 2025
From anti-ageing to precision prevention
- Treatment of pancreatitis: current study data
How can the risk-benefit profile be improved?
- Prurigo and PN